- -

Simultaneous controlled iontophoretic delivery of pramipexole and rasagiline in vitro and in vivo: Transdermal polypharmacy to treat Parkinson's disease

RiuNet: Institutional repository of the Polithecnic University of Valencia

Share/Send to

Cited by

Statistics

Simultaneous controlled iontophoretic delivery of pramipexole and rasagiline in vitro and in vivo: Transdermal polypharmacy to treat Parkinson's disease

Show full item record

Kalaria, D.; Singhal, M.; Patravale, V.; Merino Sanjuán, V.; Kalia, YN. (2018). Simultaneous controlled iontophoretic delivery of pramipexole and rasagiline in vitro and in vivo: Transdermal polypharmacy to treat Parkinson's disease. European Journal of Pharmaceutics and Biopharmaceutics. 127:204-212. https://doi.org/10.1016/j.ejpb.2018.02.031

Por favor, use este identificador para citar o enlazar este ítem: http://hdl.handle.net/10251/146285

Files in this item

Item Metadata

Title: Simultaneous controlled iontophoretic delivery of pramipexole and rasagiline in vitro and in vivo: Transdermal polypharmacy to treat Parkinson's disease
Author: Kalaria, D.R. Singhal, Mayank Patravale, V.B. Merino Sanjuán, Virginia Kalia, Yogeshvar N.
Issued date:
Abstract:
[EN] Effective treatment of Parkinson's disease (PD) involves administration of therapeutic agents with complementary mechanisms of action in order to replenish, sustain or substitute endogenous dopamine. The objective of ...[+]
Subjects: Iontophoresis , Transdermal , Dopamine agonist , MAO-B inhibitor , Patient compliance
Copyrigths: Cerrado
Source:
European Journal of Pharmaceutics and Biopharmaceutics. (issn: 0939-6411 )
DOI: 10.1016/j.ejpb.2018.02.031
Publisher:
Elsevier
Publisher version: https://doi.org/10.1016/j.ejpb.2018.02.031
Project ID:
SNSF/ISJRP 123143
Thanks:
We thank the Indo Swiss Joint Research Programme (ISJRP 123143) for financial support.
Type: Artículo

This item appears in the following Collection(s)

Show full item record